EDGAR Filing Documents for 0001615774-15-002933

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001615774-15-002933

Filing Date

2015-10-14

Accepted

2015-10-14 17:28:16

Documents

Period of Report

2015-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	s101719_10-q.htm	10-Q	436910
2	EXHIBIT 31.1	s101719_31-1.htm	EX-31.1	9356
3	EXHIBIT 31.2	s101719_31-2.htm	EX-31.2	9376
4	EXHIBIT 32.1	s101719_32-1.htm	EX-32.1	5030
5	EXHIBIT 32.2	s101719_32-2.htm	EX-32.2	4984
6	GRAPHIC	img001_v1.jpg	GRAPHIC	3531
	Complete submission text file	0001615774-15-002933.txt		3542895

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE FILE	cttc-20150331.xml	EX-101.INS	556137
8	XBRL SCHEMA FILE	cttc-20150331.xsd	EX-101.SCH	50802
9	XBRL CALCULATION FILE	cttc-20150331_cal.xml	EX-101.CAL	53461
10	XBRL DEFINITION FILE	cttc-20150331_def.xml	EX-101.DEF	201256
11	XBRL LABEL FILE	cttc-20150331_lab.xml	EX-101.LAB	357315
12	XBRL PRESENTATION FILE	cttc-20150331_pre.xml	EX-101.PRE	257069

Mailing Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824

Business Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824 (203) 368-6044

CALMARE THERAPEUTICS Inc (Filer) CIK: 0000102198 (see all company filings)